[ESC/EACTS guidelines on myocardial revascularization : Amendments 2014]

H Nef1, M Renker, C W Hamm

  • 1Medizinische Klinik I, Kardiologie und Angiologie, Universitätsklinikum Gießen, Klinikstr. 33, 35392, Gießen, Deutschland, holger.nef@me.com.

Herz
|November 20, 2014
PubMed

Insights

Identifying patients who need myocardial revascularization is crucial for effective treatment in interventional cardiology. New guidelines will help select appropriate percutaneous coronary intervention (PCI) or coronary artery bypass grafts (CABG) to avoid harm and ensure patient benefit.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Surgery
  • Clinical Guidelines

Context:

  • Myocardial revascularization is a cornerstone of treatment for coronary artery disease.
  • Percutaneous coronary intervention (PCI) and coronary artery bypass grafts (CABG) are primary revascularization methods.
  • Accurate patient selection is vital for successful outcomes.

Purpose:

  • To outline new aspects of myocardial revascularization addressed in the latest ESC/EACTS guidelines.
  • To emphasize the importance of selecting appropriate revascularization strategies.
  • To guide clinicians in avoiding interventions that may cause more harm than benefit.

Summary:

  • Effective myocardial revascularization requires precise identification of patients needing intervention.
  • The choice between PCI and CABG must be carefully considered for optimal blood flow restoration.
  • New European Society of Cardiology and European Association for Cardio-Thoracic Surgery (ESC/EACTS) guidelines introduce updated recommendations.

Impact:

  • Improved patient selection for revascularization procedures.
  • Enhanced clinical decision-making in interventional cardiology and cardiac surgery.
  • Reduced risk of adverse outcomes by avoiding unnecessary or inappropriate interventions.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.9K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
503
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
484
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
332
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
813
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
563